LR
Insider
Larry Robbins
DirectorLarry Robbins (Director) filed 5 Form 4 reports in the trailing twelve months (2 purchases, 3 sales), most often in Butterfly Network, Inc. (BFLY). Across 2 priced purchase filings, the average 21-session return was +54.0% from execution and +46.3% from disclosure (delay-adjusted; derived). The largest single filing was $317.4M of CVS (3,371,049 sh across 5 lots, as filed), executed May 19.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+54.0%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+46.3%
same 2 filings, from disclosure
Filings, ttm
5
2 buys · 3 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$363.4M
shares × price, as filed
Last traded
Aug 17
Filed Aug 17
Median ADV $75.0M across their filed names
Open performance→Volume by month
Buys $11.4M
Sells $605.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
BFLYRecent filings
BFLYSALE
Butterfly Network, Inc.
View filing →
$20.6M2,297,733 sh across 5 lots
Exec Aug 13
Filed Aug 17 · 7:01 PM ET BFLYSALE Butterfly Network, Inc. View filing → $14.0M
1,876,292 sh across 2 lots
Exec Jul 31
Filed Aug 3 · 6:11 PM ET CVSSALE CVS Health Corporation View filing → $317.4M
3,371,049 sh across 5 lots
Exec May 19
Filed May 21 · 5:30 PM ET BFLYPURCHASE Butterfly Network, Inc. View filing → $4.7M
1,558,541 sh across 3 lots
Exec Dec 3 2025
Filed Dec 5 2025 · 5:40 PM ET BFLYPURCHASE Butterfly Network, Inc. View filing → $6.8M
2,800,000 sh across 3 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:35 PM ET CVSSALE CVS Health Corporation View filing → $253.7M
3,750,000 sh across 6 lots
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET